node1	node2	edge_score	
DB01269	EGFR	1.0	
EGFR	rs2293347	0.99
EGFR		1.0
EGFR	rs712830	0.99
EGFR	rs121434569	0.99
EGFR	rs121434568	0.99
EGFR	rs712829	0.99
UBC	TRAF6	0.863464374084
EGFR	rs11568315	0.99
EGFR	UBC	0.935012238275
EGFR	rs2227983	0.99
Hypohidrotic X-linked ectodermal dysplasia	EGFR	1.0	
Hypohidrotic X-linked ectodermal dysplasia	TRAF6	1.0	
Cachexia	EGFR	1.0	
Cachexia	TRAF6	1.0	
Cachexia	UBC	1.0	
{Diphtheria, susceptibility to} (1)	EGFR	1.0	
{Diphtheria, susceptibility to} (1)	TRAF6	1.0	
Tumor necrosis	EGFR	1.0	
Tumor necrosis	TRAF6	1.0	
Drug Eruptions	EGFR	1.0	
Disorder of skeletal system	EGFR	1.0	
Papillary adenocarcinoma	EGFR	1.0	
Pleural Neoplasms	EGFR	1.0	
Sarcoma, Epithelioid	EGFR	1.0	
childhood rhabdomyosarcoma	EGFR	1.0	
Peritoneal Mesothelioma	EGFR	1.0	
Estrogen resistance	EGFR	1.0	
Hypersensitivity	EGFR	1.0	
Hypersensitivity	TRAF6	1.0	
Cervical dysplasia	EGFR	1.0	
Seborrheic keratosis	EGFR	1.0	
Adrenal Gland Hyperfunction	EGFR	1.0	
Dupuytren Contracture	EGFR	1.0	
Multiple Endocrine Neoplasia Type 2b	EGFR	1.0	
Breast cancer recurrent	EGFR	1.0	
Early gastric cancer	EGFR	1.0	
Malignant neoplasm of vulva	EGFR	1.0	
Astrocytoma, low grade	EGFR	1.0	
Pyruvate carboxylase deficiency	EGFR	1.0	
Squamous Cell Neoplasms	EGFR	1.0	
Pituitary dependent hypercortisolism	EGFR	1.0	
Dermatofibrosarcoma protuberans	EGFR	1.0	
Familial cold-induced inflammatory syndrome 1, 120100 (3)	EGFR	1.0	
Recurrent bronchitis	EGFR	1.0	
Large cell neuroendocrine carcinoma	EGFR	1.0	
Thymic Carcinoma	EGFR	1.0	
Myeloproliferative disorder, chronic, with eosinophilia	EGFR	1.0	
Neoplasm of the thymus	EGFR	1.0	
Gastrinoma	EGFR	1.0	
Xeroderma Pigmentosum, Complementation Group D	EGFR	1.0	
Staphylococcal Infections	EGFR	1.0	
Stage IV Ovarian Carcinoma	EGFR	1.0	
Adenocarcinoma in Situ	EGFR	1.0	
Complete hydatidiform mole	EGFR	1.0	
Mucinous Neoplasm	EGFR	1.0	
Primary Lesion	EGFR	1.0	
Pericardial effusion	EGFR	1.0	
Malignant neoplasm of oropharynx	EGFR	1.0	
Acinar Cell Carcinoma	EGFR	1.0	
Comedone	EGFR	1.0	
Prostate cancer recurrent	EGFR	1.0	
Sentinel node (disorder)	EGFR	1.0	
Testicular seminoma	EGFR	1.0	
Testicular seminoma	UBC	1.0	
Neoplasm of the peripheral nervous system	EGFR	1.0	
Polymyalgia Rheumatica	TRAF6	1.0	
Hemangioblastoma	EGFR	1.0	
Metastatic Carcinoma	EGFR	1.0	
Nasal polyposis	EGFR	1.0	
Nasal polyposis	TRAF6	1.0	
Malignant neoplasm of stomach stage IV	EGFR	1.0	
Diffuse Astrocytoma	EGFR	1.0	
Intracranial glioma	EGFR	1.0	
Plague	EGFR	1.0	
Neurofibromatoses	EGFR	1.0	
Stromal sarcoma	EGFR	1.0	
Clear cell sarcoma, of tendons and aponeuroses	EGFR	1.0	
Rhinovirus infection	EGFR	1.0	
Bronchogenic Carcinoma	EGFR	1.0	
CNS metastases	EGFR	1.0	
Idiopathic crescentic glomerulonephritis	EGFR	1.0	
Chronic rejection of renal transplant	EGFR	1.0	
Carcinosarcoma	EGFR	1.0	
{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3)	EGFR	1.0	
Erythroblastosis	EGFR	1.0	
Primary malignant neoplasm of brain	EGFR	1.0	
Gestational trophoblastic disease	EGFR	1.0	
Recurrent bacterial infection	EGFR	1.0	
Recurrent bacterial infection	TRAF6	1.0	
Cholesteatoma	EGFR	1.0	
Malignant neoplasm of male breast	EGFR	1.0	
Chloracne	EGFR	1.0	
Dryness of eye	EGFR	1.0	
Tumor-Associated Vasculature	EGFR	1.0	
Single tumor	EGFR	1.0	
Primary Carcinoma	EGFR	1.0	
Yolk Sac Tumor	EGFR	1.0	
Autosomal recessive polycystic kidney disease	EGFR	1.0	
Acute intermittent porphyria	EGFR	1.0	
Ganglioglioma	EGFR	1.0	
Oropharyngeal disorders	EGFR	1.0	
Recurrent pneumonia	EGFR	1.0	
Mammary Carcinoma, Human	EGFR	1.0	
Pituitary corticotropic cell adenoma	EGFR	1.0	
Dry Eye Syndromes	EGFR	1.0	
Neoplasm of the respiratory system	EGFR	1.0	
Adenosquamous carcinoma	EGFR	1.0	
CARCINOMA OF VULVA	EGFR	1.0	
Li-Fraumeni syndrome	EGFR	1.0	
Neck Neoplasms	EGFR	1.0	
Squamous cell carcinoma of mouth	EGFR	1.0	
Bile duct cancer resectable	EGFR	1.0	
Neoplasm of the gallbladder	EGFR	1.0	
Rous Sarcoma	UBC	1.0	
Ganglioneuroblastoma	EGFR	1.0	
Papillomavirus Infections	EGFR	1.0	
stage, non-small cell lung cancer	EGFR	1.0	
Phyllodes tumor, benign	EGFR	1.0	
Uterine Cancer	EGFR	1.0	
Trichomegaly	EGFR	1.0	
Peptic Esophagitis	EGFR	1.0	
Leukoplakia	EGFR	1.0	
Neurofibromas	EGFR	1.0	
Recurrent lower respiratory tract infections	EGFR	1.0	
pathologic fistula	EGFR	1.0	
Nerve Sheath Tumors	EGFR	1.0	
Brain Tumor, Primary	EGFR	1.0	
Low Grade Squamous Intraepithelial Neoplasia	EGFR	1.0	
Chromosome Xq28 deletion syndrome	EGFR	1.0	
Carcinoma, Neuroendocrine	EGFR	1.0	
Carcinoma of Male Breast	EGFR	1.0	
Lupus Vulgaris	EGFR	1.0	
Lupus Vulgaris	TRAF6	1.0	
Arnold-Chiari malformation	EGFR	1.0	
Russell-Silver syndrome	EGFR	1.0	
Biliary tract neoplasm	EGFR	1.0	
Optic neuropathy	EGFR	1.0	
Female pseudohermaphroditism	EGFR	1.0	
Malignant Fibrous Histiocytoma	EGFR	1.0	
Human papilloma virus infection	EGFR	1.0	
Graft-versus-host disease, susceptibility to	EGFR	1.0	
Graft-versus-host disease, susceptibility to	TRAF6	1.0	
Oropharyngeal squamous cell carcinoma	EGFR	1.0	
Lymphangiomyomatosis	EGFR	1.0	
Discoid lupus erythematosus	EGFR	1.0	
Discoid lupus erythematosus	TRAF6	1.0	
Huntington's chorea	TRAF6	1.0	
Huntington's chorea	UBC	1.0	
cancer recurrence	EGFR	1.0	
Adenocarcinoma, Endometrioid	EGFR	1.0	
Oropharyngeal Carcinoma	EGFR	1.0	
Stereotypy	EGFR	1.0	
Infiltrating Cervical Carcinoma	EGFR	1.0	
Primary Glioblastoma	EGFR	1.0	
Other specified disorders of breast	EGFR	1.0	
Anaplastic carcinoma	EGFR	1.0	
Intraosseous mucoepidermoid carcinoma	EGFR	1.0	
Helminthiasis	EGFR	1.0	
Breast Fibrocystic Disease	EGFR	1.0	
gliosarcoma	EGFR	1.0	
Rhabdoid tumors, somatic, 609322 (3)	EGFR	1.0	
Refractory cancer	EGFR	1.0	
Ovarian Serous Adenocarcinoma	EGFR	1.0	
Early-Stage Breast Carcinoma	EGFR	1.0	
Ameloblastoma	EGFR	1.0	
Atypical nevus	EGFR	1.0	
Extraosseous Ewings sarcoma-primitive neuroepithelial tumor	EGFR	1.0	
Papule	EGFR	1.0	
Fasciculations	EGFR	1.0	
Hyperparathyroidism 4	EGFR	1.0	
Hepatosplenic schistosomiasis	EGFR	1.0	
Carcinoma, Large Cell	EGFR	1.0	
Neoplasms, Intracranial	EGFR	1.0	
Giant cell tumor of bone	EGFR	1.0	
Malignant neoplasm of colon stage IV	EGFR	1.0	
Bronchitis	EGFR	1.0	
Nasopharyngeal cancer recurrent	EGFR	1.0	
Retroviridae Infections	EGFR	1.0	
Uremia	EGFR	1.0	
